By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...

Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...

Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets ...

W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is one of the popular penny stocks on Robinhood to buy. On March 17, SELLAS Life ...

Wave Life Sciences Ltd. (NASDAQ:WVE) shares fell 30% Thursday following the company’s announcement of interim Phase 1 data ...

Overall, the 25 largest life science employers in Southern California have more than 28,000 employees combined.

As the life sciences and Medtech sectors undergo rapid transformation, new priorities are reshaping where companies choose to grow. A new report from the Hickey Institute explores the evolving ...

For Jonathan Snover, the North Carolina Biotechnology Center's Western Region Executive Director based in Asheville, the ...

Ed Field is President of BioLabs NC. Mr. Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies. He has been responsible for ...

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...